News

Home | Market | News | News Details

News Details

(As on Jul 12, 2018, 12:03)

Zydus Cadila receives USFDA nod for migraine relief drug

Zydus Cadila has received final approval from the US health regulator to market Zolmitriptan tablets, used to relieve headache, pain, and other migraine symptom.

The company has got final approval from the US Food and Drug Administration (USFDA) to market the drug in the strengths of 2.5 mg and 5 mg, Zydus Cadila said in a BSE filing.

The drug will be produced at the group's formulations manufacturing facility at Moraiya, Ahmedabad.

The Zydus group has more than 203 approvals, and so far filed over 330 abbreviated new drug applications (ANDAs) since it started filings in 2003-04.

Meanwhile, shares of the company were trading at Rs 370.00 apiece, down 0.40 per cent from the previous close at 12:07 hours on BSE.

TRADEWELL SECURITIES LIMITED
CORPORATE MEMBER OF BOMBAY STOCK EXCHANGE OF INDIA LTD  |  MEMBER ID : 3187  |  NATIONAL STOCK EXCHANGE OF INDIA LTD  |  MEMBER ID: 12835
SEGMENTS: BSE CASH  |  BSE STAR MF  |  NSE CASH  |  NSE FO  |  NSE CD  |  NSE MF
SEBI REGN NO. INZ000171936
AMFI ARN CODE: 111875
SEBI MCX REGISTRATION NUMBER: INZ000067338, MEMBER ID: 31100
CDSL DP ID NO. : 12052700 DP SEBI REG.NO.IN-DP-CDSL-432-2007
NSE | BSE | RBI | SEBI | CDSL | MCX | AMFI

ATTENTION INVESTORS "Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with us. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.......... Issued in the interest of investors". "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with us. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day.......... Issued in the interest of investors". "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary".

(Note : Best viewed in 1024 X 768 and above resolution also in IE 9 and above all higher versions.)


Copyright © 2015 Tradewell Securities Limited. All rights reserved.

Designed, developed and content provided by dion

SMS Registration

Submit Clear

Mobile Trading

Segment

Submit Clear

logo

Submit Clear

Investors Grievances

DP Grievances
tslgrievance@tradewellmail.com

Trading Grievances
igtsl@tradewellmail.com

Invest By QFI

QFI's Can now invest in Indian Capital Markets Through Tradewell Securities ltd -
For details Contact
Mr K.Brahmaiah - 9246399440/040-23541258.

CLIENT LOGIN

NOTES:

FRANCHISEE LOGIN

NOTES:

INTERNET TRADING

NOTES: